InsidersTradesSigma
Follow the Genocea Biosciences, INC. stock price and the full insider trade history of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Operating in the Health Care sector, Genocea Biosciences, INC. has recorded 30 insider filings. Market capitalisation: €6k. The latest transaction was disclosed on 3 June 2022 (Cession). Among the most active insiders: Flechtner Jessica Baker. The full history is accessible without an account.
30
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€14,367
23 ops.
Sell Volume
56Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 3 June 2022
Declarations30 total
1,578 shares@ US$0.0615.00% mcap3.1% of flowCommon StockSEC:0001457612-22-000074:0
4,023 shares@ US$0.0638.25% mcap2.0% of flowCommon StockSEC:0001457612-22-000073:0
1,355 shares@ US$0.0612.88% mcap2.6% of flowCommon StockSEC:0001457612-22-000075:0
2,500 shares@ US$0.060124.02% mcap100.0% of flowCommon StockSEC:0001457612-22-000070:0
117,244 shares@ €0.057558.9% of flowCommon StockSEC:0001457612-22-000069:0
20,425 shares@ US$0.0653100.0% of flowCommon StockSEC:0001457612-22-000066:0
5,931,843 shares@ €0.0609100.0% of flowCommon StockSEC:0001209191-22-032330:0
24,407 shares@ US$0.076559.7% of flowCommon StockSEC:0001457612-22-000060:0
2,500 shares@ US$0.08935.47% mcap100.0% of flowCommon StockSEC:0001457612-22-000062:0
5,931,843 shares@ €0.0609100.0% of flowCommon StockSEC:0001209191-22-032327:0
16,525 shares@ US$0.088148.1% of flowCommon StockSEC:0001457612-22-000061:0
5,931,843 shares@ €0.0609100.0% of flowCommon StockSEC:0001209191-22-032322:0
5,931,843 shares@ €0.0609100.0% of flowCommon StockSEC:0001209191-22-032317:0
5,931,843 shares@ €0.0609100.0% of flowCommon StockSEC:0001209191-22-032329:0
5,931,843 shares@ €0.0609100.0% of flowCommon StockSEC:0001209191-22-032323:0
5,931,843 shares@ €0.0609100.0% of flowCommon StockSEC:0001209191-22-032331:0
5,931,843 shares@ €0.0609100.0% of flowCommon StockSEC:0001209191-22-032326:0
5,931,843 shares@ €0.0609100.0% of flowCommon StockSEC:0001209191-22-032320:0
3,924 shares@ US$1.2539.1% of flowCommon StockSEC:0001457612-22-000043:0
963 shares@ US$1.25100.0% of flowCommon StockSEC:0001457612-22-000042:0
963 shares@ US$1.2537.7% of flowCommon StockSEC:0001457612-22-000045:0
1,091 shares@ US$1.25100.0% of flowCommon StockSEC:0001457612-22-000044:0
1,212 shares@ US$1.2548.8% of flowCommon StockSEC:0001457612-22-000046:0
43,750 shares0Common StockSEC:0001457612-22-000034:0
150,000 shares0Common StockSEC:0001457612-22-000026:0
25 of 30 declarations
Acerca de Genocea Biosciences, INC.
GENOCEA BIOSCIENCES, INC. es una empresa de biotecnología centrada en el desarrollo de inmunoterapias para enfermedades infecciosas y cáncer. La empresa utiliza su plataforma de descubrimiento de vacunas para identificar objetivos inmunes únicos.